Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |